Platinum drugs have been used as a combination regimen of docetaxel and trastuzumab, which is an alternative to anthracycline, taxane, and trastuzumab-based treatments of HER2-positive early breast cancer patients [53]. Here, ERBB2 is linked to breast carcinoma.